PainChek General Discussion, page-17170

As an addendum to my earlier posting today ................

For what it is worth I personally, and through a corporate structure, own a significant number of shares shares at and average buy-in of 14.5c so yes I am down 38% (or $40K+) but unlike many I am prepared to wait and allow this opportunity time to develop. There was nothing nefarious in my earlier posting.

PCK has gone through this low before and may well do so again in the future. However it is the future that people invest in new business opportunities for -anyone expecting a pot of gold at the end of the rainbow in the relative early stages of a product lifecycle , especially with a tech style product in the health sector is either delusional or has no business sense.